• Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs.

      Lund, S H; Aspelund, T; Kirby, P; Russell, G; Einarsson, S; Palsson, O; Stefánsson, E; [ 1 ] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland [ 2 ] Risk Ehf, Reykjavik, Iceland [ 3 ] Hlth Intelligence Plc, Cambridge, England (BMJ Publishing Group, 2016-05)
      To validate a mathematical algorithm that calculates risk of diabetic retinopathy progression in a diabetic population with UK staging (R0-3; M1) of diabetic retinopathy. To establish the utility of the algorithm to reduce screening frequency in this cohort, while maintaining safety standards.
    • Retinal oxygen metabolism in healthy subjects and glaucoma patients.

      Olafsdottir, Olof Birna; Vandewalle, Evelien; Abegão Pinto, Luis; Geirsdottir, Asbjorg; De Clerck, Eline; Stalmans, Peter; Gottfredsdottir, Maria Soffia; Kristjansdottir, Jona Valgerdur; Van Calster, Joachim; Zeyen, Thierry; et al. (Bmj Publishing Group, 2014-03)
      To test whether retinal oxygen metabolism is different in glaucoma patients compared with healthy subjects.